Balcom Alexandra bought CBIO
June 2, 2026 · Form 4 insider transaction
Balcom Alexandra bought 11,050 shares of Crescent Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
11,050
Price
$0.00
Total value
N/A
InsiderBalcom Alexandra
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 2, 2026
Filing dateJune 3, 2026
Shares owned after11,050
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase 11,050 of the Issuer's ordinary shares and vests in full on the earlier of (i) June 2, 2027 or (ii) the date of the Issuer's next annual meeting of shareholders, in each case, subject to the Reporting Person's continued service to the Issuer.